The burgeoning popularity of retatrutide, initially for diabetes , is creating significant buzz within the UK , prompting a notable shift in medication trends. Availability these treatments remains a complex situation , with National Health Service approval currently limited and private clinics offering prescriptions at a premium . Concerns are bei